No connection

Search Results

CLPT vs EOLS

CLPT
ClearPoint Neuro, Inc.
BEARISH
Price
$9.07
Market Cap
$269.8M
Sector
Healthcare
AI Confidence
65%
EOLS
Evolus, Inc.
NEUTRAL
Price
$4.09
Market Cap
$266.1M
Sector
Healthcare
AI Confidence
80%

Valuation

P/E Ratio
CLPT
--
EOLS
--
Forward P/E
CLPT
-11.13
EOLS
17.04
P/B Ratio
CLPT
9.51
EOLS
-11.52
P/S Ratio
CLPT
7.3
EOLS
0.9
EV/EBITDA
CLPT
-13.53
EOLS
-12.2

Profitability

Gross Margin
CLPT
61.38%
EOLS
66.33%
Operating Margin
CLPT
-50.38%
EOLS
-0.32%
Profit Margin
CLPT
-69.08%
EOLS
-17.38%
ROE
CLPT
-95.64%
EOLS
--
ROA
CLPT
-20.41%
EOLS
-10.25%

Growth

Revenue Growth
CLPT
34.0%
EOLS
14.4%
Earnings Growth
CLPT
--
EOLS
--

Financial Health

Debt/Equity
CLPT
2.08
EOLS
--
Current Ratio
CLPT
5.91
EOLS
1.9
Quick Ratio
CLPT
4.94
EOLS
1.44

Dividends

Dividend Yield
CLPT
--
EOLS
--
Payout Ratio
CLPT
0.0%
EOLS
0.0%

AI Verdict

CLPT BEARISH

CLPT shows bearish fundamentals based on deterministic rules. Financial strength is weak (F-Score 1/9). Concerns include weak profitability or high valuation.

Strengths
Strong revenue growth of 34.0%
Risks
Low profit margin of -69.1%
Weak financial trend (Piotroski F-Score: 1/9)
High debt burden with D/E of 2.08
EOLS NEUTRAL

EOLS shows neutral fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Mixed signals with both opportunities and risks present.

Strengths
Company has established market presence
Risks
Low profit margin of -17.4%

Compare Another Pair

CLPT vs EOLS: Head-to-Head Comparison

This page compares ClearPoint Neuro, Inc. (CLPT) and Evolus, Inc. (EOLS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile